basically we have joined the 200 where the funds run the space - the funds operate and look at financials for revenue…. Basically all they care about - not overly keen to take on risk especially in this Marco environment!
The names like recently Roche caught some eyes but who’s to say it wasn’t just retail? Until some kind person posts some broker data
If the results due soon come back positive I think we should see a run…. Fingers crossed
AIMHO
Ann: Oncolytic Virotherapy CF33 Patent Granted in Japan, page-74
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.005(9.26%) |
Mkt cap ! $433.6M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.9¢ | 5.4¢ | $1.489M | 25.99M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 35252 | 5.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 1753430 | 24 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |